Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis

Author： Opdenakker G. Nelissen I. Van Damme J.

Publisher： Elsevier

ISSN： 1474-4422

Source： Lancet Neurology, Vol.2, Iss.12, 2003-12, pp. : 747-756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis

By Leppert D Ford J Stabler G Grygar C Lienert C Huber S Miller KM Hauser SL Kappos L

Brain, Vol. 121, Iss. 12, 1998-12 ,pp. : 2327-2334

Oxford University Press

Access to resources Recommend Favorite

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study

By Lee MA Palace J Stabler G Ford J Gearing A Miller K

Brain, Vol. 122, Iss. 2, 1999-02 ,pp. : 191-197

Oxford University Press

Access to resources Recommend Favorite

Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis

By Schmidt J.

Brain, Vol. 126, Iss. 8, 2003-08 ,pp. : 1895-1904

Oxford University Press

Access to resources Recommend Favorite

Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis

By Linker Ralf A.

Brain, Vol. 133, Iss. 8, 2010-08 ,pp. : 2248-2263

Oxford University Press

Access to resources Recommend Favorite

The B cell response in multiple sclerosis

By Owens Gregory P. Bennett Jeffrey L. Gilden Donald H. Burgoon Mark P.

Neurological Research, Vol. 28, Iss. 3, 2006-04 ,pp. : 236-244

Maney Publishing

Access to resources Recommend Favorite